High Level of Adherence to Alirocumab and Concomitant Background Treatments for Patients With Heterozygous Familial Hypercholesterolemia in the ODYSSEY Open-Label Extension Study

被引：0
|
作者：
Farnier, Michel A.
Hovingh, G. Kees
Langslet, Gisle
Dufour, Robert
Baccara-Dinet, Marie T.
Din-Bell, Chantal
Manvelian, Garen
Guyton, John R.
机构：
来源：
CIRCULATION | 2017年 / 136卷
关键词：
PCSK9; Adherence; Cholesterol-lowering drugs; Hyperlipidemia; LDL;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
15057
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Long-term safety and efficacy of alirocumab in patients with heterozygous familial hypercholesterolemia: An open-label extension of the ODYSSEY program
    Farnier, Michel
    Hovingh, G. Kees
    Langslet, Gisle
    Dufour, Robert
    Baccara-Dinet, Marie T.
    Din-Bell, Chantal
    Manvelian, Garen
    Guyton, John R.
    ATHEROSCLEROSIS, 2018, 278 : 307 - 314
  • [2] Regional Variations in Alirocumab Dosing Patterns in Patients with Heterozygous Familial Hypercholesterolemia During an Open-Label Extension Study
    Gisle Langslet
    G. Kees Hovingh
    John R. Guyton
    Marie T. Baccara-Dinet
    Alexia Letierce
    Garen Manvelian
    Michel Farnier
    Cardiovascular Drugs and Therapy, 2020, 34 : 515 - 523
  • [3] Regional Variations in Alirocumab Dosing Patterns in Patients with Heterozygous Familial Hypercholesterolemia During an Open-Label Extension Study
    Langslet, Gisle
    Hovingh, G. Kees
    Guyton, John R.
    Baccara-Dinet, Marie T.
    Letierce, Alexia
    Manvelian, Garen
    Farnier, Michel
    CARDIOVASCULAR DRUGS AND THERAPY, 2020, 34 (04) : 515 - 523
  • [4] ALIROCUMAB TREATMENT IN A REAL WORLD SETTING: SAFETY UPDATE FROM AN OPEN-LABEL TREATMENT EXTENSION TO THE ODYSSEY PROGRAM FOR PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    Guyton, John R.
    Hovingh, G. Kees
    Langslet, Gisle
    Dufour, Robert
    Baccara-Dinet, Marie
    Din-Bell, Chantal
    Manvelian, Garen
    Farnier, Michel
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 1660 - 1660
  • [5] Long-term safety and efficacy of alirocumab in South African patients with heterozygous familial hypercholesterolaemia: the ODYSSEY Open-Label Extension study
    Blom, Dirk J.
    Breedt, Johannes
    Burgess, Lesley J.
    Ebrahim, Iftikhar O.
    Ellis, Graham
    Soma, Prashilla
    van der Walt, Eugene
    Naidoo, Poobalan
    van Tonder, Alet
    Raal, Frederick J.
    CARDIOVASCULAR JOURNAL OF AFRICA, 2019, 30 (05) : 279 - 284
  • [6] Alirocumab dosing patterns during 40 months of open-label treatment in patients with heterozygous familial hypercholesterolemia
    Hovingh, G. Kees
    Guyton, John R.
    Langslet, Gisle
    Dufour, Robert
    Baccara-Dinet, Marie T.
    Din-Bell, Chantal
    Manvelian, Garen
    Farnier, Michel
    JOURNAL OF CLINICAL LIPIDOLOGY, 2018, 12 (06) : 1463 - 1470
  • [7] Open-label therapy with alirocumab in patients with heterozygous familial hypercholesterolemia: Results from three years of treatment
    Dufour, Robert
    Bergeron, Jean
    Gaudet, Daniel
    Weiss, Robert
    Hovingh, G. Kees
    Qing, Zhizhi
    Yang, Feng
    Andisik, Matthew
    Torri, Albert
    Pordy, Robert
    Gipe, Daniel A.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 228 : 754 - 760
  • [8] REGIONAL VARIATIONS IN ALIROCUMAB DOSING PATTERNS DURING AN OPEN-LABEL EXTENSION STUDY IN PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLAEMIA
    Langslet, G.
    Hovingh, G. K.
    Guyton, J. R.
    Baccara-Dinet, M. T.
    Letierce, A.
    Manvelian, G.
    Farnier, M.
    ATHEROSCLEROSIS, 2019, 287 : E37 - E38
  • [9] ODYSSEY HIGH FH: Efficacy and Safety of Alirocumab in Patients With Severe Heterozygous Familial Hypercholesterolemia
    Ginsberg, Henry N.
    Rader, Daniel J.
    Raal, Frederick J.
    Guyton, John R.
    Lorenzato, Christelle
    Pordy, Robert
    Baccara-Dinet, Marie T.
    Stroes, Eric S.
    CIRCULATION, 2014, 130 (23) : 2119 - 2119
  • [10] EVOLOCUMAB IN PEDIATRIC HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA: RESULTS FROM THE HAUSER OPEN-LABEL EXTENSION STUDY
    Santos, Raul
    Ruzza, Andrea
    Hovingh, G. Kees
    Stefanutti, Claudia
    Mach, Francois
    Descamps, Olivier
    Bergeron, Jean
    Wang, Bei
    Bartuli, Andrea
    Buonuomo, Paola Sabrina
    Greber-Platzer, Susanne
    Luirink, Ilse
    Raal, Frederick J.
    Kastelein, John J. P.
    Wiegman, Albert
    Gaudet, Daniel
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 1476 - 1476
12345